Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CarnoSyn Brands, a division of Natural Alternatives International, is a leading global supplier of patented beta-alanine, a premier ingredient in the sports nutrition and wellness industries. The company's flagship product, CarnoSyn, is clinically proven to increase muscle carnosine levels, which helps buffer lactic acid and delay muscle fatigue during high-intensity exercise. Beyond sports performance, the brand has expanded into the SR CarnoSyn line, focusing on healthy aging, cognitive function, and systemic wellness through sustained-release delivery. CarnoSyn is backed by over 55 clinical studies and holds numerous global patents, making it a gold standard for ingredient quality and safety in the nutraceutical market. The brand operates through a licensing model, partnering with major supplement manufacturers to include its high-quality, banned-substance-tested ingredients in their formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CarnoSyn Brands.